Geneos Therapeutics

Geneos Therapeutics

Verified
Developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.

Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$85m (Public information from Sep 2023)
Whitemarsh Township Pennsylvania (HQ)
No columns specified